Director of Research
Maria leads the scientific strategy of the Foundation. She is responsible for setting research objectives, evaluating fresh leads and commercial partners, and engaging with stakeholders within the academic, clinical and patient communities.
Maria has over ten years of research experience in the field of PI3K/PTEN signalling. Prior to joining the Foundation, she worked as a Postdoctoral Research Assistant at University College London in the research group of Prof Bart Vanhaesebroeck, a world leader in PI3K who discovered the PI3Kdelta isoform, the targeting of which has been successfully translated into an approved therapy for blood cancers. Maria’s research was focused on understanding the molecular mechanism of action of PI3Ks and their role in regulating health and disease. In addition to her own research, Maria played a key part in shaping the scientific strategy of the group by coordinating and critically evaluating research projects.
Maria holds a PhD in Molecular Medicine from Vita-Salute San Raffaele University, Milan, and an MSc in Biochemistry from the University of Helsinki, Finland.
Ask me about: our scientifc strategy, drug repositioning, clinical trials, partnerships